The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Cardiovascular benefits of omega-3 fatty acids
Abstract
Cardiac societies recommend the intake of 1 g/day of the two omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for cardiovascular disease prevention, treatment after a myocardial infarction, prevention of sudden death, and secondary prevention of cardiovascular disease. These recommendations are based on a body of scientific evidence that encompasses literally thousands of publications. Of four large scale intervention studies three also support the recommendations of these cardiac societies. One methodologically questionable study with a negative result led a Cochrane meta-analysis to a null conclusion. This null conclusion, however, has not swayed the recommendations of the cardiac societies mentioned, and has been refuted with good reason by scientific societies. Based on the scientific evidence just mentioned, we propose a new risk factor to be considered for sudden cardiac death, the omega-3 index. It is measured in red blood cells, and is expressed as a percentage of EPA + DHA of total fatty acids. An omega-3 index of >8% is associated with 90% less risk for sudden cardiac death, as compared to an omega-3 index of <4%. The omega-3 index as a risk factor for sudden cardiac death has striking similarities to LDL as a risk factor for coronary artery disease. Moreover, the omega-3 index reflects the omega-3 fatty acid status of a given individual (analogous to HbA1c reflecting glucose homeostasis). The omega-3 index can therefore be used as a goal for treatment with EPA and DHA. As is the case now for LDL, in the future, the cardiac societies might very well recommend treatment with EPA and DHA to become goal oriented (e.g. an omega-3 index>8%).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610 · cited 3×
“Reductions in cardiovascular events have been demonstrated in endpoint studies with two servings of fatty fish per week,1g/dayofa85%EPA+DHAconcentrateintheformof an ethyl ester, and 1.8 g/day of EPA as an ethyl ester [ 30 ,32,36].”
BackgroundInfluentialDe Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174516 · Cited by 2,104
(1999) · PubMed · Cited by 2,062
Management of acute myocardial infarction in patients presenting with ST-segment elevation
VandeWerf, F. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00618-8 · Cited by 1,448
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311 · cited 3×
“Time course analyses of the occurrence of the clinical endpoints demonstrated diverging curves, all favoring the intervention [ 33 ].”
BackgroundMethodInfluentialEUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
Backer, G. D., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-3-57-65 · Cited by 1,267
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146
The Omega-3 Index: A new risk factor for death from coronary heart disease?
Harris, W. S., & von Schacky, C. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2004.02.030 · Cited by 1,111
Self-citationSiscovick, D. S. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530170043030 · Cited by 920 · cited 3×
“[7,8]. However, when considering biomarkers of omega-3 fatty acids, a steep concentration-risk dependence is observed: Persons with 6.5% omega-3 fatty acids in red blood cell membranes have 90% less risk for sudden cardiac death as compared to persons with 3.3% [ 9 ].”
BackgroundMethodInfluentialThies, F., Garry, J. M., Yaqoob, P., Rerkasem, K., Williams, J., Shearman, C. P., Gallagher, P. J., Calder, P. C., & Grimble, R. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12468-3 · Cited by 739 · cited 2×
“DHA. In a randomized controlled trial in patients waiting for surgical carotid endarterectomy, unstable plaques were stabilized [ 24 ].”
BackgroundHooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676 · cited 4×
“[ 6 ]). In the overall conclusions, however, this was not considered.”
BackgroundResultInfluentialSmith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.026 · Cited by 671
Leaf, A., Kang, J. X., Xiao, Y.-F., & Billman, G. E. (2003) · Circulation · doi:10.1161/01.cir.0000069566.78305.33 · Cited by 605
Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., & Tsugane, S. (2006) · Circulation · doi:10.1161/circulationaha.105.581355 · Cited by 557
N-3 Fatty Acids for the Prevention of Atrial Fibrillation After Coronary Artery Bypass Surgery
Calò, L., Bianconi, L., Colivicchi, F., Lamberti, F., Loricchio, M. L., de Ruvo, E., Meo, A., Pandozi, C., Staibano, M., & Santini, M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.079 · Cited by 508
von Schacky, C., Angerer, P., Kothny, W., Theisen, K., & Mudra, H. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00003 · Cited by 487
Self-citationIntake of Fish and Omega-3 Fatty Acids and Risk of Stroke in Women
Iso, H. (2001) · JAMA · doi:10.1001/jama.285.3.304 · Cited by 481
Fish Intake and Risk of Incident Atrial Fibrillation
Mozaffarian, D., Psaty, B. M., Rimm, E. B., Lemaitre, R. N., Burke, G. L., Lyles, M. F., Lefkowitz, D., & Siscovick, D. S. (2004) · Circulation · doi:10.1161/01.cir.0000138154.00779.a5 · Cited by 456
Lack of benefit of dietary advice to men with angina: results of a controlled trial
Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., Fehily, A. M., Breay, P., Ashton, T., Zotos, P. C., Haboubi, N. A. A., & Elwood, P. C. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601539 · Cited by 409
Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials
Mozaffarian, D., Geelen, A., Brouwer, I. A., Geleijnse, J. M., Zock, P. L., & Katan, M. B. (2005) · Circulation · doi:10.1161/circulationaha.105.556886 · Cited by 399
Raitt, M. H., Connor, W. E., Morris, C., Kron, J., Halperin, B., Chugh, S. S., McClelland, J., Cook, J., MacMurdy, K., Swenson, R., et al. (2005) · JAMA · doi:10.1001/jama.293.23.2884 · Cited by 371
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake
Leaf, A., Albert, C. M., Josephson, M., Steinhaus, D., Kluger, J., Kang, J. X., Cox, B., Zhang, H., & Schoenfeld, D. (2005) · Circulation · doi:10.1161/circulationaha.105.549527 · Cited by 364
Fish Consumption and Risk of Stroke in Men
He, K. (2002) · JAMA · doi:10.1001/jama.288.24.3130 · Cited by 334
Harris, W. S., Sands, S. A., Windsor, S. L., Ali, H. A., Stevens, T. L., Magalski, A., Porter, C. B., & Borkon, A. M. (2004) · Circulation · doi:10.1161/01.cir.0000142292.10048.b2 · Cited by 325
Self-citationMANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION
Werf, F. V. D., Ardissino, D., Betriu, A., Cokkinos, D., Falk, E., Fox, K., Julian, D., Lengyel, M., Neumann, F. J., Ruzyllo, W., et al. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-2-62-95 · Cited by 323
n−3 Fatty acid supplements in rheumatoid arthritis
Kremer, J. M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.349s · Cited by 303
Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency
Eritsland, J., Arnesen, H., Grønseth, K., Fjeld, N. B., & Abdelnoor, M. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89130-8 · Cited by 252
Tavazzi, L., Tognoni, G., Franzosi, M. G., Latini, R., Maggioni, A. P., Marchioli, R., Nicolosi, G. L., & Porcu, M. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.001 · Cited by 240
Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty Acids: A Comprehensive Strategy
VON SCHACKY, C. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-890 · Cited by 214
Self-citationO’Keefe, J. H., Abuissa, H., Sastre, A., Steinhaus, D. M., & Harris, W. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.025 · Cited by 207
Self-citationErkkilä, A. T., Lehto, S., Pyörälä, K., & Uusitupa, M. I. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.1.65 · Cited by 200
Sontrop, J., & Campbell, M. K. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2005.11.005 · Cited by 176
Update of the guidelines on sudden cardiac death of the European Society of Cardiology
Priori, S. (2003) · European Heart Journal · doi:10.1016/s0195-0668x(02)00809-6 · Cited by 170
Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia
Schrepf, R., Limmert, T., Weber, P. C., Theisen, K., & Sellmayer, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16105-9 · Cited by 160
DeBacker, G., Ambrosioni, E., & Borch-Johnsen, K. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.12.022 · Cited by 158
Yokoyama, M., & Origasa, H. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00367-3 · Cited by 127
von Schacky, C. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.251 · Cited by 118
The role of omega-3 fatty acids in cardiovascular disease
von Schacky, C. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0086-y · Cited by 118
Ness, A., Hughes, J., Elwood, P., Whitley, E., Smith, G., & Burr, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601342 · Cited by 111
Morgan, D. R., Dixon, L., Hanratty, C. G., El-Sherbeeny, N. A., Hamilton, P., McGrath, L. T., Leahey, W. J., Johnston, G., & McVeigh, G. E. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.075 · Cited by 80
n-3 fatty acids and the risk of sudden cardiac death. Emphasis on heart rate variability.
Christensen, J. H. (2003) · PubMed · Cited by 70
Omega-3 fatty acids for intermittent claudication
Campbell, A., Price, J. F., & Hiatt, W. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003833.pub4 · Cited by 69
Extending the cardiovascular benefits of omega-3 fatty acids
Harris, W. S. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0050-0 · Cited by 58
Self-citationn−3 fatty acids, heart rate variability, and sudden cardiac death
Christensen, J. H., & Schmidt, E. B. (2001) · Lipids · doi:10.1007/s11745-001-0693-9 · Cited by 40
Fish intake and risk of incident atrial fibrillation
Mozaffarian, D., Psaty, B. M., & Romm, E. B. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.10.011 · Cited by 29
Ness, A., Ashfield-Watt, P. A. L., WHITING, J. M., Smith, G. D., Hughes, J., & Burr, M. L. (2004) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2004.00506.x · Cited by 25
Raitt, M. H., We, C., & Morris, C. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.08.248 · Cited by 22
Risks and benefits of omega 3 fats: A few thoughts on systematic review
He, K., & Song, Y. (2006) · BMJ · doi:10.1136/bmj.332.7546.915-a · Cited by 16
Rolle des Körpergewichts für die Prävention der koronaren Herzkrankheit
Wirth, A. G., & Gohlke, H. (2005) · Zeitschrift für Kardiologie · doi:10.1007/s00392-005-1305-z · Cited by 8
Cited by
Saini, R. K., & Keum, Y.-S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.049 · Cited by 1,281
The Mediterranean Diet, its Components, and Cardiovascular Disease
Widmer, R. J., Flammer, A. J., Lerman, L. O., & Lerman, A. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.10.014 · Cited by 963
“A multitude of meta-analyses have shown a potential cardiovascular disease morbidity and mortality benefit for mainly secondary prevention with increased fish intake (19-28).”
BackgroundEndothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
“Lessons from genetically modified animals—Knocking out preproET-1, endothelin-converting enzyme 1 or ETA receptor leads to lethality in homozygous animals and therefore does not allow a proper appraisal of the role of ET-1 in cardiovascular physiology (Von Websky et al. 2009).”
BackgroundInfluentialRusso, G. L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.020 · Cited by 844
Endothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806
Metadata
- Authors
- VONSCHACKY, C., & HARRIS, W.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-15
- Volume
- 73
- Issue
- 2
- Pages
- 310-315
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2126889659
- Cited by
- 335
- References
- 54
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.